Driving Program Awareness through Stakeholder Collaboration
This article explores strategies to enhance Patient Service Programs (PSPs) awareness through digital engagement and provider collaboration.
Standardization and the Evolving REMS Landscape
Learn about the FDA’s new guidance, the challenges of standardization, and how UBC is driving innovation in REMS implementation using modern APIs from UBC’s VP of Data Intelligence and Program Analytics, Jim Shamp.
The Evolution of Patient Support for Cell and Gene Therapy Products
Discover UBC’s insights from the Cell & Gene Meeting on the Mesa, the unique challenges patients face, and the importance of tailored support services to ensure successful treatment journeys
The impact of CKD: Why better, accessible treatments and diagnostics are crucial
Supporting National Kidney Week 2024
Podcast | Boosting Patient Adherence: The Power of Clinical Support Programs
UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.
The Importance of Good Collaboration between Different Vendors to Ensure Compliance with Global and Local Regulations
In the realm of pharmaceuticals, regulatory compliance is paramount to ensure patient safety. With the complex environment of safety reporting, several vendors may be involved at global and local levels for performing submission activities to health authorities, ethics committees and investigators. Director of UBC Global Case Processing, Myrto Ioannidi and UBC Team Manager, Esther Aparicio review […]
DCTs: Beyond Hype and To a Hybrid Future
Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.
The Importance of Choosing the Right Pharmacovigilance Partner and Safety Physician
For most pharmaceutical companies, hiring a PV team will help alleviate some of the work of the existing internal team.
Putting the ‘Patient’ Back in Patient Services
Putting the patient back in patient services means we do more, go deeper, and customize offerings.
EMA/HMA Revised Guidance on Risk Minimization Measures
UBC is the leading provider of evidence development solutions with expertise in uniting evidence and access.
